Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX.
Des Guetz
G
G
Department of Oncology, Avicenne Hospital, Bodigny, France. Gaetan.des-guetz@wanadoo.fr
Lecaille
C
C
Mariani
P
P
Bennamoun
M
M
Uzzan
B
B
Nicolas
P
P
Boisseau
A
A
Sastre
X
X
Cucherousset
J
J
Lagorce
C
C
Schischmanoff
P O
PO
Morere
J F
JF
D000328:Adult; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D053842:Microsatellite Instability; D008875:Middle Aged; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage
D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil